Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Heron Therapeutics, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1983-01-01

Employees: 126

Market Cap: $292.7M

Website: http://www.herontx.com

Clinical Trials

Pediatric Postoperative Analgesia Herniorrhaphy Study

Phase 2

Withdrawn

Conditions: Analgesia

Interventions: Drug: HTX-011
Drug: Bupivacaine HCl
Device: Luer Lock Applicator

First Posted Date: 2019-04-19

Last Posted Date: 2023-06-05

Lead Sponsor: Heron Therapeutics

Registration Number: NCT03922048

Herniorrhaphy Study for Opioid Elimination

Phase 3

Completed

Conditions: Analgesia

Interventions: Drug: HTX-011
Device: Luer lock applicator
Drug: Ibuprofen
Drug: Acetaminophen

First Posted Date: 2019-04-08

Last Posted Date: 2022-02-21

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 115

Registration Number: NCT03907176

Locations: 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸
Horizon Clinical Research, La Mesa, California, United States
🇺🇸
Sharp Grossmont Hospital, La Mesa, California, United States

and more 26 locations

Phase 2 Bunionectomy HTX-011 Administration Study

Phase 2

Completed

Conditions: Postoperative Pain

Interventions: Drug: HTX-011
Device: Luer Lock applicator
Device: Vial access device
Drug: aprepitant

First Posted Date: 2018-10-24

Last Posted Date: 2023-06-26

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 78

Registration Number: NCT03718039

Locations: 🇺🇸
Endeavor Clinical Trials, LLC, San Antonio, Texas, United States

Bupivacaine HCl PK and Safety in Augmentation Mammoplasty

Phase 4

Completed

Conditions: Analgesia

Interventions: Drug: Bupivacaine HCl

First Posted Date: 2018-10-15

Last Posted Date: 2018-12-07

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 30

Registration Number: NCT03705065

Locations: 🇺🇸
Hermann Drive Surgical Hospital, Houston, Texas, United States

Phase 2 Herniorrhaphy Study for Opioid Elimination

Phase 2

Completed

Conditions: Postoperative Pain

Interventions: Drug: HTX-011
Device: Luer lock applicator
Device: Vial access device
Drug: Ibuprofen
Drug: Acetaminophen
Drug: Ketorolac

First Posted Date: 2018-10-04

Last Posted Date: 2021-10-25

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 63

Registration Number: NCT03695367

Locations: 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸
JBR Clinical Research, Salt Lake City, Utah, United States

Bunionectomy Study for Postoperative Analgesia (EPOCH 1)

Phase 3

Completed

Conditions: Postoperative Pain

Interventions: Drug: HTX-011
Drug: Saline Placebo
Drug: Bupivacaine HCl
Device: Luer-lock applicator
Device: Vial access device

First Posted Date: 2017-09-28

Last Posted Date: 2025-03-07

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 412

Registration Number: NCT03295721

Locations: 🇺🇸
Springhill Medical Center, Mobile, Alabama, United States
🇺🇸
Orthopaedic Specialists of North America, PLLC, Mesa, Arizona, United States
🇺🇸
Arizona Research Center, Phoenix, Arizona, United States

and more 12 locations

Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)

Phase 3

Completed

Conditions: Postoperative Pain

Interventions: Drug: HTX-011
Drug: Saline placebo
Drug: Bupivacaine HCl
Device: Luer-lock applicator
Device: Vial access device

First Posted Date: 2017-08-02

Last Posted Date: 2025-03-07

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 418

Registration Number: NCT03237481

Locations: 🇺🇸
Eliza Coffee Memorial Hospital, Florence, Alabama, United States
🇺🇸
Shoals Medical Trials, Inc., Sheffield, Alabama, United States
🇺🇸
Arizona Research Center, Phoenix, Arizona, United States

and more 21 locations

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

Phase 2

Completed

Conditions: Postoperative Pain

Interventions: Drug: HTX-011
Drug: Saline Placebo
Drug: Bupivicaine HCl
Drug: Ropivacaine

First Posted Date: 2017-01-10

Last Posted Date: 2025-03-07

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 285

Registration Number: NCT03015532

Phase 2B Upper Extremity Nerve Block Study

Phase 2

Completed

Conditions: Postoperative Pain

Interventions: Drug: HTX-011
Drug: Bupivacaine HCl without epinephrine
Drug: Saline Placebo

First Posted Date: 2017-01-05

Last Posted Date: 2025-03-07

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 243

Registration Number: NCT03011333

Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Phase 2

Completed

Conditions: Postoperative Pain
Bunions

Interventions: Drug: HTX-002
Biological: Saline Placebo
Drug: HTX-011A
Drug: HTX-011B
Drug: Bupivacaine HCl
Drug: HTX-009

First Posted Date: 2016-05-05

Last Posted Date: 2023-10-04

Lead Sponsor: Heron Therapeutics

Target Recruit Count: 430

Registration Number: NCT02762929

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy